Insider · CIK 0001210238
Kenneth Bate
Files at MDGL (MADRIGAL PHARMACEUTICALS, INC.), ATXS (Astria Therapeutics, Inc.). First filing Feb 28, 2025, latest Feb 28, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDGL: MADRIGAL PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | MADRIGAL PHARMACEUTICALS, INC. | $7.1M 20,000 shares | -91% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | AGrant or award Common Stock | +715 | $0.00 | $0 | 2,627 | Jun 24, 2025 |
| Jun 20, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +1,290 | $0.00 | $0 | 1,290 | Jun 24, 2025 |
| Jun 11, 2025 | ATXS Astria Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +26,550 | $0.00 | $0 | 26,550 | Jun 12, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock | +6,000 | $111.06 | $666k | 7,912 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock | +9,470 | $65.06 | $616k | 17,382 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Common Stock | +4,530 | $9.45 | $43k | 21,912 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -100 | $351.01 | $35k | 21,812 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -500 | $351.99 | $176k | 21,312 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -238 | $353.83 | $84k | 21,074 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -8,545 | $355.08 | $3.0M | 12,529 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -2,791 | $356.51 | $995k | 9,738 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -2,038 | $357.27 | $728k | 7,700 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -3,548 | $358.33 | $1.3M | 4,152 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -2,024 | $359.21 | $727k | 2,128 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -216 | $360.07 | $78k | 1,912 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -6,000 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -9,470 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -4,530 | $0.00 | $0 | 5,470 | Feb 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.